APPLICATION
ANDA203561
TYPE
ANDA
ORIGINAL APPROVAL
2019-01-14
LATEST ACTION
2024-04-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
HYDROCHLOROTHIAZIDEPrescription
HYDROCHLOROTHIAZIDE 12.5MG · CAPSULE · ORAL
Approval history
2024-04-30Labeling · Supplement 5 · standardAP
2024-04-30Labeling · Supplement 3 · standardAP
2019-01-14UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.